A Review of Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Receiving Combination Therapy

Background: Inflammatory Bowel Disease (IBD) impacts millions worldwide, presenting a major challenge to healthcare providers and patients. The advent of biologic therapies has enhanced the prognosis, but many patients exhibit primary or secondary non-response, underscoring the need for rigorous mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sanket, Yarur, Andres J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607463/
https://www.ncbi.nlm.nih.gov/pubmed/37892715
http://dx.doi.org/10.3390/jcm12206577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607463/
https://www.ncbi.nlm.nih.gov/pubmed/37892715
http://dx.doi.org/10.3390/jcm12206577

Ejemplares similares